Patients’ characteristics
Characteristic . | All patients (n = 101) . | Propositi (n = 67) . | Relatives (n = 34) . | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
No. . | % . | Mean . | SD . | No. . | % . | Mean . | SD . | No. . | % . | Mean . | SD . | |
Demographics | ||||||||||||
Males | 33 | 32.7 | 22 | 32.8 | 11 | 32.4 | ||||||
Age at clinical diagnosis, y | 29.2 | 16.8 | 32.7 | 15.6 | 22.3 | 17.1 | ||||||
Age at molecular diagnosis, y | 37.1 | 17.7 | 41.4 | 16.8 | 27.7 | 16.1 | ||||||
Circumstances of diagnosis | ||||||||||||
Incidental findings | 18 | 17.8 | 18 | 26.8 | NA | |||||||
Before surgery | 21 | 20.8 | 21 | 31.3 | NA | |||||||
Pregnancy | 10 | 9.9 | 10 | 14.9 | NA | |||||||
Thrombosis | 7 | 6.9 | 7 | 10.4 | NA | |||||||
Bleeding | 12 | 11.9 | 12 | 17.9 | NA | |||||||
Familial screening | 34 | 33.7 | NA | 34 | 100 | |||||||
Laboratory values | ||||||||||||
Fibrinogen activity, g/L | 0.80 | 0.4 | 0.79 | 0.4 | 0.82 | 0.4 | ||||||
Fibrinogen antigen, g/L | 2.86 | 1.0 | 2.90 | 1.0 | 2.77 | 1.0 | ||||||
Prolonged TT* | 78 | 87.6 | 53 | 89.8 | 25 | 83.3 | ||||||
Prolonged RT† | 52 | 89.7 | 37 | 92.5 | 15 | 83.3 | ||||||
Platelets, g/L | 271.9 | 67.2 | 265.8 | 67.1 | 283.1 | 67 | ||||||
Bleeding phenotype | 48 | 47.5 | 34 | 50.8 | 14 | 41.2 | ||||||
Cutaneous | 21 | 20.8 | 12 | 17.9 | 9 | 26.5 | ||||||
Epistaxis | 8 | 7.9 | 6 | 9.0 | 2 | 5.9 | ||||||
Minor wound | 7 | 6.9 | 4 | 6.0 | 3 | 9.9 | ||||||
Oral cavity | 7 | 6.9 | 3 | 4.5 | 4 | 11.8 | ||||||
Gastrointestinal | 4 | 4.0 | 4 | 6.0 | 0 | 0 | ||||||
Hemarthrosis | 1 | 1.0 | 1 | 1.5 | 0 | 0 | ||||||
Postsurgery | 9 | 8.9 | 9 | 13.4 | 0 | 0 | ||||||
Menorrhagia‡ | 20 | 29.4 | 16 | 35.6 | 4 | 17.4 |
Characteristic . | All patients (n = 101) . | Propositi (n = 67) . | Relatives (n = 34) . | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
No. . | % . | Mean . | SD . | No. . | % . | Mean . | SD . | No. . | % . | Mean . | SD . | |
Demographics | ||||||||||||
Males | 33 | 32.7 | 22 | 32.8 | 11 | 32.4 | ||||||
Age at clinical diagnosis, y | 29.2 | 16.8 | 32.7 | 15.6 | 22.3 | 17.1 | ||||||
Age at molecular diagnosis, y | 37.1 | 17.7 | 41.4 | 16.8 | 27.7 | 16.1 | ||||||
Circumstances of diagnosis | ||||||||||||
Incidental findings | 18 | 17.8 | 18 | 26.8 | NA | |||||||
Before surgery | 21 | 20.8 | 21 | 31.3 | NA | |||||||
Pregnancy | 10 | 9.9 | 10 | 14.9 | NA | |||||||
Thrombosis | 7 | 6.9 | 7 | 10.4 | NA | |||||||
Bleeding | 12 | 11.9 | 12 | 17.9 | NA | |||||||
Familial screening | 34 | 33.7 | NA | 34 | 100 | |||||||
Laboratory values | ||||||||||||
Fibrinogen activity, g/L | 0.80 | 0.4 | 0.79 | 0.4 | 0.82 | 0.4 | ||||||
Fibrinogen antigen, g/L | 2.86 | 1.0 | 2.90 | 1.0 | 2.77 | 1.0 | ||||||
Prolonged TT* | 78 | 87.6 | 53 | 89.8 | 25 | 83.3 | ||||||
Prolonged RT† | 52 | 89.7 | 37 | 92.5 | 15 | 83.3 | ||||||
Platelets, g/L | 271.9 | 67.2 | 265.8 | 67.1 | 283.1 | 67 | ||||||
Bleeding phenotype | 48 | 47.5 | 34 | 50.8 | 14 | 41.2 | ||||||
Cutaneous | 21 | 20.8 | 12 | 17.9 | 9 | 26.5 | ||||||
Epistaxis | 8 | 7.9 | 6 | 9.0 | 2 | 5.9 | ||||||
Minor wound | 7 | 6.9 | 4 | 6.0 | 3 | 9.9 | ||||||
Oral cavity | 7 | 6.9 | 3 | 4.5 | 4 | 11.8 | ||||||
Gastrointestinal | 4 | 4.0 | 4 | 6.0 | 0 | 0 | ||||||
Hemarthrosis | 1 | 1.0 | 1 | 1.5 | 0 | 0 | ||||||
Postsurgery | 9 | 8.9 | 9 | 13.4 | 0 | 0 | ||||||
Menorrhagia‡ | 20 | 29.4 | 16 | 35.6 | 4 | 17.4 |